Skip to content
LexBuild

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Electronic Submissions of Medical Device Registration and Listing

---
identifier: "/us/fr/2025-16630"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Electronic Submissions of Medical Device Registration and Listing"
title_number: 0
title_name: "Federal Register"
section_number: "2025-16630"
section_name: "Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Electronic Submissions of Medical Device Registration and Listing"
positive_law: false
currency: "2025-08-29"
last_updated: "2025-08-29"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2025-16630"
document_type: "notice"
publication_date: "2025-08-29"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "90 FR 42251"
fr_volume: 90
docket_ids:
  - "Docket No. FDA-2025-N-1330"
comments_close_date: "2025-09-29"
fr_action: "Notice."
---

#  Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Electronic Submissions of Medical Device Registration and Listing

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget  (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

**DATES:**

Submit written comments (including recommendations) on the collection of information by September 29, 2025.

**ADDRESSES:**

To ensure that comments on the information collection are received, OMB recommends that written comments be submitted to *https://www.reginfo.gov/public/do/PRAMain.* Find this particular information collection by selecting “Currently under Review—Open for Public Comments” or by using the search function. The OMB control number for this information collection is 0910-0625. Also include the FDA docket number found in brackets in the heading of this document.

**FOR FURTHER INFORMATION CONTACT:**

Amber Sanford, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-8867, *[email protected].*

**SUPPLEMENTARY INFORMATION:**

In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.

**Electronic Submission of Medical Device Registration and Listing—21 CFR Part 807, Subparts A Through D**

**OMB Control Number 0910-0625—Extension**

This information collection supports FDA statutes and regulations. Under section 510 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 360) and part 807, subparts A through D (21 CFR part 807, subparts A *,* B *,* C *,* and D), medical device establishment owners and operators are required to electronically submit establishment registration and device listing information. Complete and accurate registration and listing information is necessary to accomplish a number of statutory and regulatory objectives, such as: (1) Identification of establishments producing marketed medical devices, (2) identification of establishments producing a specific device when that device is in short supply or is needed for national emergency, (3) facilitation of recalls for devices marketed by owners and operators of device establishments, (4) identification and cataloguing of marketed devices, (5) administering post marketing surveillance programs for devices, (6) identification of devices marketed in violation of the law, (7) identification and control of devices imported into the country from foreign establishments, (8) and scheduling and planning inspections of registered establishments under section 704 of the FD&C Act (21 U.S.C. 374).

Respondents to this information collection are owners or operators of establishments that engage in the manufacturing, preparation, propagation, compounding, or processing of a device or devices, who must register their establishments and submit listing information for each of their devices in commercial distribution. Notwithstanding certain exceptions, foreign device establishments that manufacture, prepare, propagate, compound, or process a device that is imported or offered for import into the United States must also comply with the registration and listing requirements. The number of respondents is based on data from the FDA Unified Registration and Listing System (FURLS).

In the *Federal Register* of June 20, 2025 (90 FR 26304), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received.

FDA estimates the burden of this collection of information as follows:

| 21 CFR part | Number of | Number of | Total annual responses | Average | Total hours |
| --- | --- | --- | --- | --- | --- |
| 807.20(a)(5) 
                            
                             Initial Submittal of Manufacturer Information by Initial Importers (FDA 3673) | 2,219 | 1 | 2,219 | 1.75 | 3883 |
| 807.20(a)(5) 
                            
                             Annual Submittal of Manufacturer Information by Initial Importers (FDA 3673) | 2,219 | 1 | 2,219 | 0.1 | 222 |
| 807.21(a) 
                            
                             Creation of electronic system account (FDA 3673) | 8,876 | 1 | 8,876 | 0.5 | 4,438 |
| 807.21(b) 
                            
                             Annual Request for Waiver from Electronic Registration & Listing | 1 | 1 | 1 | 1 | 1 |
| 807.21(b) 
                            
                             Initial Request for Waiver from Electronic Registration & Listing | 1 | 1 | 1 | 1 | 1 |
| 807.22(a) 
                            
                             Initial Registration & Listing (FDA 3673) | 2,106 | 1 | 2,106 | 1 | 2,106 |
| 807.22(b)(1) 
                            
                             Annual Registration (FDA 3673) | 30,280 | 1 | 30,280 | 0.5 | 15,140 |
| 807.22(b)(2) 
                            
                             Other updates of Registration (FDA 3673) | 3,906 | 1 | 3,906 | 0.5 | 1,953 |
| 807.22(b)(3) 
                            
                             Annual Update of Listing Information (FDA 3673) | 28,925 | 1 | 28,925 | 0.5 | 14,463 |
| 807.22(b)(4) Changes to listing information (outside of annual listing requirement period): Voluntary reporting of transfer of 510(k) clearance in FURLS (outside of annual listing requirement period) | 4,080 | 1 | 4,080 | 0.25 | 1,020 |
| Submission of 510(k) transfer documentation when more than one party lists the same 510(k) | 2,033 | 1 | 2,033 | 4 | 8,132 |
| 807.26(e) 
                            
                             Labeling & Advertisement Submitted at FDA Request | 1 | 1 | 1 | 1 | 1 |
| 807.34(a) 
                            
                             Initial Registration & Listing when Electronic Filing Waiver Granted | 1 | 1 | 1 | 1 | 1 |
| 807.34(a) 
                            
                             Annual Registration & Listing when Electronic Filing Waiver granted | 1 | 1 | 1 | 1 | 1 |
| 807.40(b)(2) 
                            
                             Annual Update of US Agent Information (FDA 3673) | 3,410 | 1 | 3,410 | 0.5 | 1,705 |
| 807.40(b)(3) 
                            
                             US Agent Responses to FDA Requests for Information (FDA 3673) | 1,535 | 1 | 1,535 | 0.25 | 384 |
| 807.41(a) 
                            
                             Identification of initial importers defined in 21 CFR 807.3(g) by foreign establishments (FDA 3673) | 2,955 | 1 | 2,955 | 0.5 | 1,478 |
| 807.41(b) 
                            
                             Identification of other importers (defined in 21 CFR 807.3(x) and (y) that facilitate import by foreign establishments (FDA 3673) | 3,234 | 1 | 3,234 | 0.5 | 1,617 |
| Total |  |  |  |  | 56,546 |

| 21 CFR part | Number of recordkeepers | Number of records per recordkeeper | Total annual records | Average burden per | Total hours |
| --- | --- | --- | --- | --- | --- |
| 807.25(d) 
                            
                             List of Officers, Directors & Partners | 22,338 | 1 | 22,338 | .25 | 5,585 |
| 807.26 
                            
                             Labeling & Advertisements Available for Review | 17,032 | 4 | 68,128 | .5 | 34,064 |
| Total |  |  |  |  | 39,649 |

Our estimated burden for the information collection reflects an overall decrease of 17,637 hours and a corresponding decrease of 34,526 responses. Burden estimates are based on recent registration and listing information collected from establishments registering for the first time (initial registration) and establishments re-registering. We attribute this adjustment to a decrease in the number of submissions we received over the last approval period.

Grace R. Graham,

Deputy Commissioner for Policy, Legislation, and International Affairs.